180 related articles for article (PubMed ID: 3487240)
1. Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction.
Schelbert HR; Henze E; Sochor H; Grossman RG; Huang SC; Barrio JR; Schwaiger M; Phelps ME
Am Heart J; 1986 Jun; 111(6):1055-64. PubMed ID: 3487240
[TBL] [Abstract][Full Text] [Related]
2. C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism.
Schelbert HR; Henze E; Schon HR; Keen R; Hansen H; Selin C; Huang SC; Barrio JR; Phelps ME
Am Heart J; 1983 Mar; 105(3):492-504. PubMed ID: 6600872
[No Abstract] [Full Text] [Related]
3. [Fatty acid metabolism using C-11 palmitate: (1). Resting study].
Tamaki N; Yonekura Y; Magata Y; Saji H; Fujibayashi Y; Sasayama S; Yamashita K; Ohtani H; Fujita T; Yamada T
Kaku Igaku; 1990 Apr; 27(4):313-21. PubMed ID: 2376917
[TBL] [Abstract][Full Text] [Related]
4. Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis.
Grover-McKay M; Schelbert HR; Schwaiger M; Sochor H; Guzy PM; Krivokapich J; Child JS; Phelps ME
Circulation; 1986 Aug; 74(2):281-92. PubMed ID: 3731419
[TBL] [Abstract][Full Text] [Related]
5. Competition between palmitate and ketone bodies as fuels for the heart: study with positron emission tomography.
Vanoverschelde JL; Wijns W; Kolanowski J; Bol A; Decoster PM; Michel C; Cogneau M; Heyndrickx GR; Essamri B; Melin JA
Am J Physiol; 1993 Mar; 264(3 Pt 2):H701-7. PubMed ID: 8456973
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reserve in normal myocardium assessed by positron emission tomography with C-11 palmitate.
Tamaki N; Kawamoto M; Takahashi N; Yonekura Y; Magata Y; Nohara R; Kambara H; Kawai C; Konishi J
Ann Nucl Med; 1991 Jul; 5(2):53-8. PubMed ID: 1777350
[TBL] [Abstract][Full Text] [Related]
7. Retention and clearance of C-11 palmitic acid in ischemic and reperfused canine myocardium.
Schwaiger M; Schelbert HR; Keen R; Vinten-Johansen J; Hansen H; Selin C; Barrio J; Huang SC; Phelps ME
J Am Coll Cardiol; 1985 Aug; 6(2):311-20. PubMed ID: 4019919
[TBL] [Abstract][Full Text] [Related]
8. Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy.
Sochor H; Schelbert HR; Schwaiger M; Henze E; Phelps ME
Eur J Nucl Med; 1986; 12 Suppl():S66-9. PubMed ID: 3490381
[TBL] [Abstract][Full Text] [Related]
9. Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically.
Fox KA; Abendschein DR; Ambos HD; Sobel BE; Bergmann SR
Circ Res; 1985 Aug; 57(2):232-43. PubMed ID: 4017196
[TBL] [Abstract][Full Text] [Related]
10. C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. IV. In vivo evaluation of acute demand-induced ischemia in dogs.
Schelbert HR; Henze E; Keen R; Schon HR; Hansen H; Selin C; Huang SC; Barrio JR; Phelps ME
Am Heart J; 1983 Oct; 106(4 Pt 1):736-50. PubMed ID: 6604447
[No Abstract] [Full Text] [Related]
11. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
[TBL] [Abstract][Full Text] [Related]
12. I-123 heptadecanoic acid--value and limitations in comparison with C-11 palmitate.
Schön HR
Eur J Nucl Med; 1986; 12 Suppl():S16-9. PubMed ID: 3490371
[TBL] [Abstract][Full Text] [Related]
13. External assessment of myocardial metabolism with C-11 palmitate in vivo.
Goldstein RA; Klein MS; Welch MJ; Sobel BE
J Nucl Med; 1980 Apr; 21(4):342-8. PubMed ID: 6966678
[TBL] [Abstract][Full Text] [Related]
14. Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography.
Armbrecht JJ; Buxton DB; Brunken RC; Phelps ME; Schelbert HR
Circulation; 1989 Oct; 80(4):863-72. PubMed ID: 2791250
[TBL] [Abstract][Full Text] [Related]
15. Metabolic fate of radiolabeled palmitate in ischemic canine myocardium: implications for positron emission tomography.
Rosamond TL; Abendschein DR; Sobel BE; Bergmann SR; Fox KA
J Nucl Med; 1987 Aug; 28(8):1322-9. PubMed ID: 3497240
[TBL] [Abstract][Full Text] [Related]
16. Validation of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids.
DeGrado TR; Kitapci MT; Wang S; Ying J; Lopaschuk GD
J Nucl Med; 2006 Jan; 47(1):173-81. PubMed ID: 16391202
[TBL] [Abstract][Full Text] [Related]
17. Assessment of myocardial fatty acid metabolism with 1-11C-palmitate.
Geltman EM
J Nucl Cardiol; 1994; 1(2 Pt 2):S15-22. PubMed ID: 9420693
[TBL] [Abstract][Full Text] [Related]
18. Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography.
Geltman EM; Smith JL; Beecher D; Ludbrook PA; Ter-Pogossian MM; Sobel BE
Am J Med; 1983 May; 74(5):773-85. PubMed ID: 6601460
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of myocardial fatty acid metabolism using PET.
Bergmann SR; Weinheimer CJ; Markham J; Herrero P
J Nucl Med; 1996 Oct; 37(10):1723-30. PubMed ID: 8862319
[TBL] [Abstract][Full Text] [Related]
20. Assessment of myocardial triglyceride oxidation with PET and 11C-palmitate.
Kisrieva-Ware Z; Coggan AR; Sharp TL; Dence CS; Gropler RJ; Herrero P
J Nucl Cardiol; 2009; 16(3):411-21. PubMed ID: 19212800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
